Top compounds associated with response to CT45A9


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.072 0.1
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.12 0.1
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.058 0.1
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.17 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA SN-38 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA necrostatin-7 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.057 0.1
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.057 0.1
Download CSV